Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Moore

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Bacteriology|June 1, 1982
Ligase-deficient yeast cells exhibit defective DNA rejoining and enhanced gamma ray sensitivityC W Moore
Antimicrobial Agents and Chemotherapy|April 1, 1982
Modulation of bleomycin cytotoxicityC W Moore
Cancer Research|March 1, 1982
Control of in vivo (cellular) phleomycin sensitivity by nuclear genotype, growth phase, and metal ionsC W Moore
Cancer Research|December 15, 1989
Cleavage of cellular and extracellular Saccharomyces cerevisiae DNA by bleomycin and phleomycinC W Moore
Cancer Research|December 1, 1988
Internucleosomal cleavage and chromosomal degradation by bleomycin and phleomycin in yeastC W Moore
Mutation Research|August 1, 1978
Responses of radiation-sensitive mutants of Saccharomyces cerevisiae to lethal effects of bleomycinC W Moore
Mutation Research|September 1, 1978
Bleomycin-induced mutation and recombination in Saccharomyces cerevisiaeC W Moore
Hospital Materiel Management Quarterly|October 8, 1981
Group purchasing: past, present and futureC W Moore
Antimicrobial Agents and Chemotherapy|July 1, 1994
Potentiation of bleomycin cytotoxicity in Saccharomyces cerevisiaeC W Moore
Journal of Bacteriology|September 1, 1982
cdc9 ligase-defective mutants of Saccharomyces cerevisiae exhibit lowered resistance to lethal effects of bleomycinC W Moore
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Bacteriology|June 1, 1982
Ligase-deficient yeast cells exhibit defective DNA rejoining and enhanced gamma ray sensitivityC W Moore
Antimicrobial Agents and Chemotherapy|April 1, 1982
Modulation of bleomycin cytotoxicityC W Moore
Cancer Research|March 1, 1982
Control of in vivo (cellular) phleomycin sensitivity by nuclear genotype, growth phase, and metal ionsC W Moore
Cancer Research|December 15, 1989
Cleavage of cellular and extracellular Saccharomyces cerevisiae DNA by bleomycin and phleomycinC W Moore
Cancer Research|December 1, 1988
Internucleosomal cleavage and chromosomal degradation by bleomycin and phleomycin in yeastC W Moore
Mutation Research|August 1, 1978
Responses of radiation-sensitive mutants of Saccharomyces cerevisiae to lethal effects of bleomycinC W Moore
Mutation Research|September 1, 1978
Bleomycin-induced mutation and recombination in Saccharomyces cerevisiaeC W Moore
Hospital Materiel Management Quarterly|October 8, 1981
Group purchasing: past, present and futureC W Moore
Antimicrobial Agents and Chemotherapy|July 1, 1994
Potentiation of bleomycin cytotoxicity in Saccharomyces cerevisiaeC W Moore
Journal of Bacteriology|September 1, 1982
cdc9 ligase-defective mutants of Saccharomyces cerevisiae exhibit lowered resistance to lethal effects of bleomycinC W Moore
Pageof 5